Takahiro Iino

1.1k total citations
50 papers, 869 citations indexed

About

Takahiro Iino is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Takahiro Iino has authored 50 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Takahiro Iino's work include Proteoglycans and glycosaminoglycans research (9 papers), Osteoarthritis Treatment and Mechanisms (9 papers) and Sarcoma Diagnosis and Treatment (8 papers). Takahiro Iino is often cited by papers focused on Proteoglycans and glycosaminoglycans research (9 papers), Osteoarthritis Treatment and Mechanisms (9 papers) and Sarcoma Diagnosis and Treatment (8 papers). Takahiro Iino collaborates with scholars based in Japan, Ireland and United States. Takahiro Iino's co-authors include Akihiro Sudo, Akihiko Matsumine, Masahiro Hasegawa, Atsumasa Uchida, Tomoki Nakamura, Kunihiro Asanuma, Takao Matsubara, Toshimichi Yoshida, Masaya Tsujii and Kyoko Imanaka‐Yoshida and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Free Radical Biology and Medicine.

In The Last Decade

Takahiro Iino

48 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takahiro Iino Japan 20 289 221 179 138 123 50 869
Teruki Yanagi Japan 20 448 1.6× 291 1.3× 93 0.5× 169 1.2× 203 1.7× 112 1.1k
Catharine J. Andresen United States 17 253 0.9× 181 0.8× 80 0.4× 93 0.7× 51 0.4× 26 833
Ke Jin China 21 626 2.2× 145 0.7× 293 1.6× 103 0.7× 95 0.8× 66 1.4k
Ch.C. Zouboulis Germany 24 315 1.1× 136 0.6× 171 1.0× 131 0.9× 220 1.8× 41 1.4k
Kalu U.E. Ogbureke United States 18 589 2.0× 247 1.1× 698 3.9× 105 0.8× 62 0.5× 43 1.4k
Massimo Sabatini France 16 415 1.4× 342 1.5× 234 1.3× 42 0.3× 38 0.3× 28 1.0k
Madalina V. Nastase Germany 9 466 1.6× 82 0.4× 68 0.4× 127 0.9× 288 2.3× 12 1.1k
Katrien Van Raemdonck United States 16 268 0.9× 249 1.1× 136 0.8× 85 0.6× 32 0.3× 21 919
Terufumi Kubo Japan 20 477 1.7× 504 2.3× 72 0.4× 243 1.8× 70 0.6× 92 1.3k
Alexis Grande Italy 25 824 2.9× 310 1.4× 112 0.6× 90 0.7× 94 0.8× 70 1.6k

Countries citing papers authored by Takahiro Iino

Since Specialization
Citations

This map shows the geographic impact of Takahiro Iino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takahiro Iino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takahiro Iino more than expected).

Fields of papers citing papers by Takahiro Iino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takahiro Iino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takahiro Iino. The network helps show where Takahiro Iino may publish in the future.

Co-authorship network of co-authors of Takahiro Iino

This figure shows the co-authorship network connecting the top 25 collaborators of Takahiro Iino. A scholar is included among the top collaborators of Takahiro Iino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takahiro Iino. Takahiro Iino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asanuma, Kunihiro, Atsuhiro Nakatsuka, Tomoki Nakamura, et al.. (2024). Cryoablation for Malignant Bone and Soft Tissue Tumors and Histological Assessment of Ablated Tumors. Anticancer Research. 44(12). 5463–5476. 1 indexed citations
2.
Hasegawa, Masahiro, et al.. (2023). Role of Syndecan-4 in the Inhibition of Articular Cartilage Degeneration in Osteoarthritis. Biomedicines. 11(8). 2257–2257. 4 indexed citations
3.
Asanuma, Kunihiro, et al.. (2022). Macrophages and vimentin in tissues adjacent to megaprostheses and mesh in reconstructive surgeries. Communicative & Integrative Biology. 15(1). 168–181. 4 indexed citations
4.
Asanuma, Kunihiro, Tomoki Nakamura, Takayuki Okamoto, et al.. (2020). Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas. Scientific Reports. 10(1). 9077–9077. 38 indexed citations
5.
Nakamura, Tomoki, et al.. (2020). Anti-tumour effect of tocilizumab for osteosarcoma cell lines. Bone and Joint Research. 9(11). 821–826. 8 indexed citations
6.
Hasegawa, Masahiro, et al.. (2020). TNIIIA2, The Peptide of Tenascin-C, as a Candidate for Preventing Articular Cartilage Degeneration. Cartilage. 13(2_suppl). 1367S–1375S. 5 indexed citations
7.
Wakabayashi, Hiroki, et al.. (2019). Teriparatide improves pain-related behavior and prevents bone loss in ovariectomized mice. Journal of orthopaedic surgery. 28(1). 615553482–615553482. 8 indexed citations
8.
Suzuki, Yoshiaki, et al.. (2019). Intra-articular injection of rebamipide prevents articular cartilage degeneration in murine post-traumatic osteoarthritis models. Modern Rheumatology. 30(4). 765–772. 5 indexed citations
9.
Hasegawa, Masahiro, Yoshiaki Suzuki, Takahiro Iino, et al.. (2019). Tenascin-C promotes the repair of cartilage defects in mice. Journal of Orthopaedic Science. 25(2). 324–330. 13 indexed citations
10.
Matsubara, Takao, Tomoki Nakamura, Takahiro Iino, et al.. (2018). Carbonic anhydrase IX enhances tumor cell proliferation and tumor progression in osteosarcoma. OncoTargets and Therapy. Volume 11. 6879–6886. 18 indexed citations
11.
Wakabayashi, Hiroki, et al.. (2018). Interleukin-6 receptor inhibitor suppresses bone metastases in a breast cancer cell line. Breast Cancer. 25(5). 566–574. 24 indexed citations
12.
Nakagawa, T, et al.. (2018). The effects of bisphosphonate on pain-related behavior and immunohistochemical analyses in hindlimb-unloaded mice. Journal of Orthopaedic Science. 23(6). 1063–1069. 8 indexed citations
13.
Naito, Yohei, et al.. (2017). Alendronate inhibits hyperalgesia and suppresses neuropeptide markers of pain in a mouse model of osteoporosis. Journal of Orthopaedic Science. 22(4). 771–777. 20 indexed citations
14.
Hasegawa, Masahiro, Takahiro Iino, & Akihiro Sudo. (2016). Immune response in adverse reactions to metal debris following metal-on-metal total hip arthroplasty. BMC Musculoskeletal Disorders. 17(1). 221–221. 18 indexed citations
15.
Hasegawa, Masahiro, et al.. (2016). Tenascin-C Prevents Articular Cartilage Degeneration in Murine Osteoarthritis Models. Cartilage. 9(1). 80–88. 24 indexed citations
16.
Hamamura, Kazunori, et al.. (2015). Chondroprotective effects of Salubrinal in a mouse model of osteoarthritis. Bone and Joint Research. 4(5). 84–92. 23 indexed citations
17.
Matsumine, Akihiko, Takahiro Iino, Masahiro Hasegawa, et al.. (2010). The cleavage of N-cadherin is essential for chondrocyte differentiation. Biochemical and Biophysical Research Communications. 400(4). 493–499. 14 indexed citations
18.
Hasegawa, Masahiro, Takahiro Iino, Akihiro Sudo, et al.. (2009). Thrombin-Cleaved Osteopontin in Synovial Fluid of Subjects with Rheumatoid Arthritis. The Journal of Rheumatology. 36(2). 240–245. 37 indexed citations
19.
Wakabayashi, T., Akihiko Matsumine, Masahiro Hasegawa, et al.. (2009). Fibulin-3 negatively regulates chondrocyte differentiation. Biochemical and Biophysical Research Communications. 391(1). 1116–1121. 29 indexed citations
20.
Tsujii, Masaya, Koji Akeda, Takahiro Iino, & Atsumasa Uchida. (2009). Are BMPs Involved in Normal Nerve and Following Transection?: A Pilot Study. Clinical Orthopaedics and Related Research. 467(12). 3183–3189. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026